SCHEMBL567822

SCHEMBL567822

CC([O])CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3341813 1.00
SCHEMBL3340776 1.00
SCHEMBL22497205 0.73
SCHEMBL180102 0.73
SCHEMBL17082860 0.73
SCHEMBL15740645 0.72
SCHEMBL1749188 0.72
Isobutanol SCHEMBL969 0.70
Isobutanol SCHEMBL175952 0.70 TSHR (1.00)
SCHEMBL9576819 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3122853-B1 LIQUID CATIONIC FORMULATION AND METHOD FOR THE PRODUCTION THEREOF HENKEL AG & CO KGAA (DE) 2019-05-08 EP claimed
US-10030213-B2 Liquid cationic formulation and method for the production thereof HENKEL AG & CO. KGAA (DE) 2018-07-24 US claimed
EP-1600442-B1 HETEROARYLCARBAMOYLBENZENE DERIVATIVE MSD KK (JP) 2018-01-17 EP claimed
US-20160362635-A1 LIQUID CATIONIC FORMULATION AND METHOD FOR THE PRODUCTION THEREOF HENKEL AG & CO. KGAA (DE) 2016-12-15 US claimed
EP-2509450-A1 PREBIOTIC Technische Universität Graz (AT) 2012-10-17 EP claimed
WO-2011070010-A1 PREBIOTIC TECHNISCHE UNIVERSITÄT GRAZ (AT) 2011-06-16 WO claimed
WO-1996031476-A1 AROMATIC HYDROXYETHERS RHONE-POULENC RORER LIMITED (GB) 1996-10-10 WO claimed
EP-0449998-A4 ANTIBODY-OXIDASE CONJUGATES WITH NON-SYSTEMIC SUBSTRATES 1992-01-15 EP claimed
EP-0449998-A1 ANTIBODY-OXIDASE CONJUGATES WITH NON-SYSTEMIC SUBSTRATES BRUNSWICK CORPORATION (US) 1991-10-09 EP claimed
WO-1991000108-A1 ANTIBODY-OXIDASE CONJUGATES WITH NON-SYSTEMIC SUBSTRATES BRUNSWICK CORPORATION (US) 1991-01-10 WO claimed
EP-3892278-B1 CYCLOALKANE-1,3-DIAMINE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2024-02-28 EP disclosed
CN-117510500-A Preparation method of asperazepanones alkaloid and application of asperazepanones alkaloid as anti-inflammatory drug 中国海洋大学 2024-02-06 CN disclosed
US-20240000767-A1 COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT (DE) 2024-01-04 US disclosed
CN-117050043-A 3-phenyl dibenzofuran compound and preparation method and application thereof 中国海洋大学 2023-11-14 CN disclosed
CN-116726010-A Application of macrolide derivative in preparation of medicines for inhibiting pro-inflammatory cytokine acting agents 中国海洋大学 2023-09-12 CN disclosed
US-4563468-A ANTI-RHINOVIRUS 2-PYRIDYLCHROMANS BURROUGHS WELLCOME CO. (US) 1986-01-07 US disclosed
EP-0138420-A2 Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1985-04-24 EP disclosed
EP-0133454-A1 Derivatives of carboxysiloxanes and their use as internal mold release agents THE DOW CHEMICAL COMPANY (US) 1985-02-27 EP disclosed
US-4472341-A REACTION INJECTION MOLDING THE UPJOHN COMPANY (US) 1984-09-18 US disclosed
EP-0025600-A1 2-Pyridyl chromans and pharmaceutical compositions containing them THE WELLCOME FOUNDATION LIMITED (GB) 1981-03-25 EP disclosed